Vanguard Personalized Indexing Management, LLC Mersana Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 42,638 shares of MRSN stock, worth $16,202. This represents 0.0% of its overall portfolio holdings.
Number of Shares
42,638Holding current value
$16,202% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MRSN
# of Institutions
116Shares Held
101MCall Options Held
16.3KPut Options Held
13K-
Nextech Invest, Ltd. Zurich, V812.1MShares$4.59 Million0.97% of portfolio
-
Nextech Invest Ag12.1MShares$4.59 Million3.22% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA8.66MShares$3.29 Million0.99% of portfolio
-
Black Rock Inc. New York, NY8.38MShares$3.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.38MShares$3.18 Million0.0% of portfolio
About Mersana Therapeutics, Inc.
- Ticker MRSN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,169,296
- Market Cap $36.9M
- Description
- Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...